Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting

Archives of Internal Medicine

Volumn 164, Issue 22, 2004, Pages 2435-2441

  Narain, Sonali ^a   Richards, Hanno B ^a   Satoh, Minoru ^a   Sarmiento, Marlene ^a   Davidson, Richard ^a,b   Shuster, Jonathan ^a   Sobel, Eric ^a   Hahn, Paulette ^a   Reeves, Westley H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID;

ARTICLE; AUTOIMMUNE DISEASE; COMMUNITY CARE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT REFERRAL; PRIORITY JOURNAL; RHEUMATOLOGY; SERODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION PROCESS;

ADRENAL CORTEX HORMONES; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LUPUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY;

EID: 10344222129     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.22.2435     Document Type: Article

References (35)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
2. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23: 581-590.
3. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
4. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
5. Tanimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22:668-674.
6. Gamez-Nava JI, Gonzalez-Lopez L, Davis P, Suarez-Almazor ME. Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol. 1998;37:1215-1219.
7. Gran JT, Nordvag BY. Referrals from general practice to an outpatient rheumatology clinic: disease spectrum and analysis of referral letters. Clin Rheumatol. 2000;19:450-454.
8. Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol. 1998;25:1980-1985.
9. Schwartz G, Merenstein JH, D'Amico F, Agarwal A. Does curriculum make a difference? a comparison of family physicians with and without rheumatology training during residency. Arch Fam Med. 1994;3:263-267.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 1997;40:1725.
11. Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus. 1998;7:95-100.
12. Reeves WH, Satoh M, McCauliffe DP. Autoantibody testing by non-FITC methods. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical Immunology. 6th ed. Washington, DC: American Society of Microbiology Press; 2002:933-950.
13. Smith EL, Shmerling RH. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus. 1999;8:586-595.
14. Edworthy SM, Zatarain E, McShane DJ, Bloch DA. Analysis of the 1982 ARA lupus criteria data set by recursive partitioning methodology: new insights into the relative merit of individual criteria. J Rheumatol. 1988;15:1493-1498.
15. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol. 2001;54:211-219.
16. Hooker RS, Brown JB. Rheumatology referral patterns. HMO Pract. 1990;4:61-65.
17. Bjelle A, Magi M. Rheumatic disorders in primary care: a study of two primary care centres and a review of previous Swedish reports on primary care. Scand J Rheumatol. 1981;10:331-341.
18. Sverdrup B, Allebeck P, Allander E. Tentative diagnoses among referrals versus diagnoses established at the Department of Rheumatology. Scand J Rheumatol. 1983;12:377-378.
19. Bombardieri S, Neri R, Tartarelli G, d'Ascanio A, Giovanelli L. The clinical relevance of antinuclear antibodies in connective tissue diseases. Scand J Rheumatol Suppl. 1987;66:35-45.
20. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349:1526-1533.
21. Vila LM, Mayor AM, Valentin AH, Garcia-Soberal M, Vila S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus. 2000;9:110-115.
22. Clegg DO, Williams HJ, Singer JZ, et al. Early undifferentiated connective tissue disease, II: the frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol. 1991;18:1340-1343.
23. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997;40:1601-1611.
24. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987;69:557-565.
25. Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with anti-nuclear antibodies. J Rheumatol. 1989;16:623-625.
26. Shiel WC Jr, Jason M. The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol. 1989;16: 782-785.
27. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med. 1993;119:1198-1208.
28. Riaz S, Nowack WJ. Diagnostic problems in multiple sclerosis: overreliance on neuroimaging. South Med J. 1998;91:270-272.
29. Incalzi RA, Fuso L, Serra M, et al. Exacerbated chronic obstructive pulmonary disease: a frequently unrecognized condition. J Intern Med. 2002;252:48-55.
30. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002;16:847-858.
31. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med. 1990;112:682-698.
32. Sebastiani GD, Passiu G, Galeazzi M, Porzio F, Carcassi U. Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study. Clin Rheumatol. 1991;10:289-293.
33. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986;13:486-489.
34. Lockshin MD. Lupus and antiphospholipid antibody syndrome: either, neither, or both [editorial]. Am J Med. 1994;96:1-2.
35. Calvo-Alen J, Bastian HM, Straaton KV, Burgard SL, Mikhail IS, Alarcon GS. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum. 1995;38:1475-1484.